# OnCo record umrd (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/umrd/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "umrd" ;
  schema:name "Undetectable MRD (uMRD / MRD-negative)"@en ;
  schema:alternateName "uMRD"@en, "MRD-negative"@en, "MRD negative"@en, "MRD negativity rate"@en, "MRD-positive"@en, "MRD positive"@en, "MRD-persistent"@en, "MRD persistence"@en, "MRD-guided"@en, "MRD-driven"@en, "MRD-adapted"@en, "sustained MRD negativity"@en, "uMRD4"@en, "MRD 10^-5"@en, "MRD 10-6"@en ;
  schema:description "The test for leftover cancer cells found none, down to the sensitivity of the assay (often one cell in 100,000 or a million). It is the deepest remission we can measure and is becoming a treatment goal and trial endpoint in blood cancers."@en ;
  schema:url <https://onco.cc/terms/umrd/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Minimal_residual_disease> ;
  schema:citation <https://en.wikipedia.org/wiki/Minimal_residual_disease> ;
  onco:related <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/flow-cytometry/>, <https://onco.cc/terms/fixed-duration/>, <https://onco.cc/terms/complete-response-term/> ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/aml/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/blinatumomab/> .